Table 1.
Effect of CsIVa pretreatment on liver index, serum ALT and AST levels in mice treated with LPS.
| Groups | Control | LPS | CsIVa (mg/kg) + LPS | ||
|---|---|---|---|---|---|
| 5 mg/kg | 10 mg/kg | 20 mg/kg | |||
| Final weight(g) | 19.84 ± 1.06 | 22.61 ± 2.26## | 21.05 ± 0.87 | 20.68 ± 0.91* | 20.96 ± 0.88* |
| Liver quality(g) | 1.09 ± 0.15 | 1.32 ± 0.03## | 1.16 ± 0.04** | 1.12 ± 0.07** | 1.11 ± 0.07** |
| Liver index(%) | 4.82 ± 0.21 | 5.87 ± 0.56## | 5.51 ± 0.28 | 5.41 ± 0.41 | 5.28 ± 0.35** |
| ALT(U/L) | 7.63 ± 10.86 | 50.42 ± 9.45## | 36.61 ± 9.81 | 27.03 ± 11.31** | 23.03 ± 10.83** |
| AST(U/L) | 26.76 ± 6.51 | 81.23 ± 12.23## | 45.29 ± 9.24** | 36.55 ± 13.52** | 29.67 ± 10.38** |
The results are presented as the mean ± SD (n = 10).
##p < 0.01 vs control group. *p < 0.05, **p < 0.01 vs LPS group.